Biologics

Researchers at Osaka University in Japan used synovium-derived mesenchymal stem cells to develop a synthetic tissue to treat damaged cartilage, which previously had no effective therapies and was incurable. The first patient surgery was performed in the Phase III clinical…

RTI Surgical laid out its 2018 guidance and long-term financial goals.

Gulf Breeze, Fla.-based Andrews Institute for Orthopaedics and Sports Medicine is reporting positive results in its study to create new cartilage in the knee through stem cell injections, the Pensacola News Journal reports.

Little Rock, Ark.-based Baptist Health Spine Center physicians are encouraging patients to avoid surgery through the use of stem cell injections, according to Arkansas Matters.

Charles Krome, DO, of Somers Point, N.J.-based Shore Orthopaedic, leverages stem cells to treat various orthopedic conditions, according to Cape May County Herald.

The FDA awarded 510(k) clearance to Anika Therapeutics' HA-based bone void filler.

A study, published in The Annals of the Rheumatic Diseases, examined the impact of biological disease-modifying anti-rheumatic drugs and associated rheumatoid arthritis management guidelines on total hip and knee replacement incidence rates in Denmark.

The American Academy of Orthopaedic Surgeons published a new position statement, "Use of Emerging Biologic Therapies."

Bone Biologics completed a preclinical study on its rhNELL-1 growth factor.

Fuse Medical is acquiring CPM Medical Consultants.